☰

Adam Amiel Friedman - Publications

Affiliations: 
2007 Harvard University, Cambridge, MA, United States 
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Sahu AD, S Lee J, Wang Z, Zhang G, Iglesias-Bartolome R, Tian T, Wei Z, Miao B, Nair NU, Ponomarova O, Friedman AA, Amzallag A, Moll T, Kasumova G, Greninger P, et al. Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy. Molecular Systems Biology. 15: e8323. PMID 30858180 DOI: 10.15252/Msb.20188323  0.323
2017 Ducker GS, Ghergurovich JM, Mainolfi N, Suri V, Jeong SK, Hsin-Jung Li S, Friedman A, Manfredi MG, Gitai Z, Kim H, Rabinowitz JD. Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 114: 11404-11409. PMID 29073064 DOI: 10.1073/Pnas.1706617114  0.303
2017 Friedman AA, Xia Y, Trippa L, Le LP, Igras V, Frederick DT, Wargo JA, Tanabe KK, Lawrence DP, Neuberg DS, Flaherty KT, Fisher D. Feasibility of ultra-high-throughput functional screening of melanoma biopsies for discovery of novel cancer drug combinations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28446504 DOI: 10.1158/1078-0432.Ccr-16-3029  0.378
2015 Friedman AA, Letai A, Fisher DE, Flaherty KT. Precision medicine for cancer with next-generation functional diagnostics. Nature Reviews. Cancer. PMID 26536825 DOI: 10.1038/Nrc4015  0.308
2015 Friedman AA, Amzallag A, Pruteanu-Malinici I, Baniya S, Cooper ZA, Piris A, Hargreaves L, Igras V, Frederick DT, Lawrence DP, Haber DA, Flaherty KT, Wargo JA, Ramaswamy S, Benes CH, et al. Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment. Plos One. 10: e0140310. PMID 26461489 DOI: 10.1371/Journal.Pone.0140310  0.368
2013 Bergwitz C, Wee MJ, Sinha S, Huang J, DeRobertis C, Mensah LB, Cohen J, Friedman A, Kulkarni M, Hu Y, Vinayagam A, Schnall-Levin M, Berger B, Perkins LA, Mohr SE, et al. Genetic determinants of phosphate response in Drosophila. Plos One. 8: e56753. PMID 23520455 DOI: 10.1371/Journal.Pone.0056753  0.447
2011 Friedman AA, Tucker G, Singh R, Yan D, Vinayagam A, Hu Y, Binari R, Hong P, Sun X, Porto M, Pacifico S, Murali T, Finley RL, Asara JM, Berger B, et al. Proteomic and functional genomic landscape of receptor tyrosine kinase and ras to extracellular signal-regulated kinase signaling. Science Signaling. 4: rs10. PMID 22028469 DOI: 10.1126/Scisignal.2002029  0.615
2011 Friedman AA, Perrimon N, VanHook AM. Science Signaling Podcast: 25 October 2011 Science Signaling. 4: pc22-pc22. DOI: 10.1126/Scisignal.2002560  0.517
2009 Yang X, Friedman A, Nagpal S, Perrimon N, Asara JM. Use of a label-free quantitative platform based on MS/MS average TIC to calculate dynamics of protein complexes in insulin signaling. Journal of Biomolecular Techniques : Jbt. 20: 272-7. PMID 19949701  0.34
2009 Kaplow IM, Singh R, Friedman A, Bakal C, Perrimon N, Berger B. RNAiCut: automated detection of significant genes from functional genomic screens. Nature Methods. 6: 476-7. PMID 19564846 DOI: 10.1038/Nmeth0709-476  0.616
2007 Friedman A, Perrimon N. Genetic screening for signal transduction in the era of network biology. Cell. 128: 225-31. PMID 17254958 DOI: 10.1016/J.Cell.2007.01.007  0.52
2007 Perrimon N, Friedman A, Mathey-Prevot B, Eggert US. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens. Drug Discovery Today. 12: 28-33. PMID 17198970 DOI: 10.1016/J.Drudis.2006.10.006  0.503
2006 Friedman A, Perrimon N. A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Nature. 444: 230-4. PMID 17086199 DOI: 10.1038/Nature05280  0.573
2006 Kulkarni MM, Booker M, Silver SJ, Friedman A, Hong P, Perrimon N, Mathey-Prevot B. Evidence of off-target effects associated with long dsRNAs in Drosophila melanogaster cell-based assays. Nature Methods. 3: 833-8. PMID 16964256 DOI: 10.1038/Nmeth935  0.526
2006 Friedman A, Perrimon N. High-throughput approaches to dissecting MAPK signaling pathways. Methods (San Diego, Calif.). 40: 262-71. PMID 16844385 DOI: 10.1016/J.Ymeth.2006.05.002  0.573
2004 Friedman A, Perrimon N. Genome-wide high-throughput screens in functional genomics. Current Opinion in Genetics & Development. 14: 470-6. PMID 15380236 DOI: 10.1016/J.Gde.2004.07.010  0.561
Show low-probability matches.